The clinicopathologic characteristics of kidney diseases related to monotypic IgA deposits

Kidney International

Volumn 91, Issue 3, 2017, Pages 720-728

  Vignon, Marguerite ^a   Cohen, Camille ^a   Faguer, Stanislas ^b   Noel, Laure Hélène ^a   Guilbeau, Celine ^b   Rabant, Marion ^a   Higgins, Sarah ^a   Hummel, Aurélie ^a   Hertig, Alexandre ^c   Francois, Hélène ^d   Lequintrec, Moglie ^e   Vilaine, Eve ^f   Knebelmann, Bertrand ^a   Pourrat, Jacques ^b   Chauveau, Dominique ^b   Goujon, Jean Michel ^g   Javaugue, Vincent ^g   Touchard, Guy ^g   El Karoui, Khalil ^h   Bridoux, Frank ^g,i  

^a HÔPITAL NECKER ENFANTS MALADES   (France)

^b CHU RANGUEIL   (France)

^c HÔPITAL TENON   (France)

^d BICÊTRE HOSPITAL   (France)

^e MONTPELLIER UNIVERSITY HOSPITAL   (France)

^f LABORATOIRE DES SCIENCES DU CLIMAT ET DE L ENVIRONNEMENT   (France)

^g POITIERS UNIVERSITY HOSPITAL   (France)

^h HENRI MONDOR HOSPITAL   (France)

ⁱ UNIVERSITY OF LIMOGES   (France)

Author keywords

glomerular disease; monoclonal gammopathy of renal significance; monoclonal IgA deposits

Indexed keywords

IMMUNOGLOBULIN A; BIOLOGICAL MARKER; HEAVY CHAIN DISEASE PROTEINS, HUMAN; IMMUNOGLOBULIN HEAVY CHAIN;

ADULT; AGED; ALPHA HEAVY CHAIN DEPOSITION DISEASE; ARTICLE; CLINICAL ARTICLE; CLINICAL FEATURE; CONTROLLED STUDY; DISEASE ASSOCIATION; FEMALE; FOLLOW UP; GLOMERULONEPHRITIS; HEAVY CHAIN DISEASE; HISTOPATHOLOGY; HUMAN; HUMAN TISSUE; IMMUNOGLOBULIN A PROLIFERATIVE GLOMERULONEPHRITIS; IMMUNOGLOBULIN DEPOSITION; KIDNEY DISEASE; MALE; MONOCLONAL IMMUNOGLOBULINEMIA; MONOTYPIC IMMUNOGLOBULIN A DEPOSITION; PATHOPHYSIOLOGY; PROGNOSIS; RETROSPECTIVE STUDY; BIOPSY; CELL PROLIFERATION; CLINICAL TRIAL; DIFFERENTIAL DIAGNOSIS; DISEASE COURSE; DRUG EFFECTS; FLUORESCENT ANTIBODY TECHNIQUE; FRANCE; GLOMERULONEPHRITIS, IGA; IMMUNOLOGY; KIDNEY; MIDDLE AGED; MULTICENTER STUDY; MULTIPLE MYELOMA; PATHOLOGY; PREDICTIVE VALUE; TIME FACTOR; ULTRASTRUCTURE; VERY ELDERLY;

ADULT; AGED; AGED, 80 AND OVER; BIOMARKERS; BIOPSY; CELL PROLIFERATION; DIAGNOSIS, DIFFERENTIAL; DISEASE PROGRESSION; FEMALE; FLUORESCENT ANTIBODY TECHNIQUE; FRANCE; GLOMERULONEPHRITIS; GLOMERULONEPHRITIS, IGA; HEAVY CHAIN DISEASE; HUMANS; IMMUNOGLOBULIN A; IMMUNOGLOBULIN ALPHA-CHAINS; IMMUNOGLOBULIN GAMMA-CHAINS; KIDNEY; MALE; MIDDLE AGED; MULTIPLE MYELOMA; PREDICTIVE VALUE OF TESTS; PROGNOSIS; RETROSPECTIVE STUDIES; TIME FACTORS;

EID: 85008674730     PISSN: 00852538     EISSN: 15231755     Source Type: Journal    
DOI: 10.1016/j.kint.2016.10.026     Document Type: Article

References (31)

1. 1 Leung, N., Bridoux, F., Hutchison, C.A., et al. Monoclonal gammopathy of renal significance: when MGUS is no longer undetermined or insignificant. Blood 120 (2012), 4292–4295.
2. 2 Fermand, J.-P., Bridoux, F., Kyle, R.A., et al. How I treat monoclonal gammopathy of renal significance (MGRS). Blood 122 (2013), 3583–3590.
3. 3 Bridoux, F., Leung, N., Hutchison, C.A., et al. Diagnosis of monoclonal gammopathy of renal significance. Kidney Int 87 (2015), 698–711.
4. 4 Nasr, S.H., Satoskar, A., Markowitz, G.S., et al. Proliferative glomerulonephritis with monoclonal IgG deposits. J Am Soc Nephrol 20 (2009), 2055–2064.
5. 5 Wyatt, R.J., Julian, B.A., IgA nephropathy. N Engl J Med 368 (2013), 2402–2414.
6. 6 Alexander, M.P., Nasr, S.H., Watson, D.C., et al. Renal crescentic alpha heavy chain deposition disease: a report of 3 cases and review of the literature. Am J Kidney Dis 58 (2011), 621–625.
7. 7 Borza, D.-B., Chedid, M.F., Colon, S., et al. Recurrent Goodpasture's disease secondary to a monoclonal IgA1-kappa antibody autoreactive with the alpha1/alpha2 chains of type IV collagen. Am J Kidney Dis 45 (2005), 397–406.
8. 8 Moulis, G., Huart, A., Guitard, J., et al. IgA-mediated anti-glomerular basement membrane disease: an uncommon mechanism of Goodpasture's syndrome. Clin Kidney J 5 (2012), 545–548.
9. 9 Cohen, C., Royer, B., Javaugue, V., et al. Bortezomib produces high hematological response rates with prolonged renal survival in monoclonal immunoglobulin deposition disease. Kidney Int 88 (2015), 1135–1143.
10. 10 Lewis, K.G., Bercovitch, L., Dill, S.W., et al. Acquired disorders of elastic tissue: part II. decreased elastic tissue. J Am Acad Dermatol 51 (2004), 165–185.
11. 11 Birchmore, D., Sweeney, C., Choudhury, D., et al. IgA multiple myeloma presenting as Henoch-Schönlein purpura/polyarteritis nodosa overlap syndrome. Arthritis Rheum 39 (1996), 698–703.
12. 12 Kaneko, S., Usui, J., Narimatsu, Y., et al. Renal involvement of monoclonal immunoglobulin deposition disease associated with an unusual monoclonal immunoglobulin A glycan profile. Clin Exp Nephrol 14 (2010), 389–395.
13. 13 Setoguchi, K., Kawashima, Y., Tokumoto, T., et al. Proliferative glomerulonephritis with monoclonal immunoglobulin A light-chain deposits in the renal allograft: proliferative glomerulonephritis with IgA. Nephrology 19 (2014), 49–51.
14. 14 Dosa, S., Cairns, S.A., Mallick, N.P., et al. Relapsing Henoch-Schönlein syndrome with renal involvement in a patient with an IgA monoclonal gammopathy. A study of the results of immunosuppressant and cytotoxic therapy. Nephron 26 (1980), 145–148.
15. 15 Alpers, C.E., Tu, W.H., Hopper, J., et al. Single light chain subclass (kappa chain) immunoglobulin deposition in glomerulonephritis. Hum Pathol 16 (1985), 294–304.
16. 16 Miura, N., Uemura, Y., Suzuki, N., et al. An IgA1-lambda-type monoclonal immunoglobulin deposition disease associated with membranous features in a patient with chronic hepatitis C viral infection and rectal cancer. Clin Exp Nephrol 14 (2010), 90–93.
17. 17 Nagae H, Tsuchimoto A, Tsuruya K, et al. Clinicopathological significance of monoclonal IgA deposition in patients with IgA nephropathy [e-pub ahead of print]. Clin Exp Nephrol. http://dx.doi.org/10.1007/s10157–016–1275–7. Accessed May 2016.
18. 18 Lai, K.N., Lai, F.M., Lo, S.T., et al. Light chain composition of IgA in IgA nephropathy. Am J Kidney Dis 11 (1988), 425–429.
19. 19 Conley, M.E., Cooper, M.D., Michael, A.F., Selective deposition of immunoglobulin A1 in immunoglobulin A nephropathy, anaphylactoid purpura nephritis, and systemic lupus erythematosus. J Clin Invest 66 (1980), 1432–1436.
20. 20 Suzuki, S., Kobayashi, H., Sato, H., et al. Immunohistochemical characterization of glomerular IgA deposits in IgA nephropathy. Clin Nephrol 33 (1990), 66–71.
21. 21 Boumediene, A., Oblet, C., Oruc, Z., et al. Gammopathy with IgA mesangial deposition provides a monoclonal model of IgA nephritogenicity and offers new insights into its molecular mechanisms. Nephrol Dial Transplant 26 (2011), 3930–3937.
22. 22 Oruc, Z., Oblet, C., Boumediene, A., et al. IgA structure variations associate with immune stimulations and IgA mesangial deposition. J Am Soc Nephrol 27 (2016), 2748–2761.
23. 23 Gregersen, H., Mellemkjaer, L., Ibsen, J.S., et al. The impact of M-component type and immunoglobulin concentration on the risk of malignant transformation in patients with monoclonal gammopathy of undetermined significance. Haematologica 86 (2001), 1172–1179.
24. 24 Bridoux, F., Hugue, V., Coldefy, O., et al. Fibrillary glomerulonephritis and immunotactoid (microtubular) glomerulopathy are associated with distinct immunologic features. Kidney Int 62 (2002), 1764–1775.
25. 25 Levey, A.S., Bosch, J.P., Lewis, J.B., et al. A more accurate method to estimate glomerular filtration rate from serum creatinine: a new prediction equation. Modification of Diet in Renal Disease Study Group. Ann Intern Med 130 (1999), 461–470.
26. 26 Beaume, A., Brizard, A., Dreyfus, B., et al. High incidence of serum monoclonal Igs detected by a sensitive immunoblotting technique in B-cell chronic lymphocytic leukemia. Blood 84 (1994), 1216–1219.
27. 27 Frébet, E., Abraham, J., Geneviève, F., et al. A GEIL flow cytometry consensus proposal for quantification of plasma cells: application to differential diagnosis between MGUS and myeloma. Cytometry B Clin Cytom 80 (2011), 176–185.
28. 28 van Dongen, J.J.M., Langerak, A.W., Brüggemann, M., et al. Design and standardization of PCR primers and protocols for detection of clonal immunoglobulin and T-cell receptor gene recombinations in suspect lymphoproliferations: report of the BIOMED-2 Concerted Action BMH4-CT98–3936. Leukemia 17 (2003), 2257–2317.
29. 29 Bridoux F, Javaugue V, Bender S, et al. Unravelling the immunopathological mechanisms of heavy chain deposition disease with implications for clinical management. Kidney Int., in press.
30. 30 Palladini, G., Hegenbart, U., Milani, P., et al. A staging system for renal outcome and early markers of renal response to chemotherapy in AL amyloidosis. Blood 124 (2014), 2325–2332.
31. 31 Palladini, G., Dispenzieri, A., Gertz, M.A., et al. New criteria for response to treatment in immunoglobulin light chain amyloidosis based on free light chain measurement and cardiac biomarkers: impact on survival outcomes. J Clin Oncol 30 (2012), 4541–4549.